We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Roche has signed a $1.7 billion agreement with Blueprint Medicines to develop and commercialize Blueprint’s pralesetinib for treatment of patients with RET-altered cancers. Read More
The FDA said yesterday that it has reviewed more than 230 clinical trials of potential COVID-19 treatments so far through its Coronavirus Treatment Acceleration Program (CTAP). Read More
Senate Democrats are calling on Congress for $25 billion in emergency funding to support the production and distribution of a COVID-19 vaccine — and for the Trump administration to lay out a distribution plan for a COVID-19 vaccine or vaccines no later than Aug. 7. Read More
Moderna’s potential COVID-19 vaccine generated neutralizing antibodies in patients, according to a phase 1 trial run by the NIH’s National Institute of Allergy and Infectious Diseases (NIAID). Read More